Unique ID issued by UMIN | UMIN000030864 |
---|---|
Receipt number | R000035240 |
Scientific Title | A prospective study of salvage radiotherapy combined with horrmone therapy for high-risk recurrent prostate cancer after radical prostatectomy |
Date of disclosure of the study information | 2018/04/01 |
Last modified on | 2022/07/23 19:25:36 |
A prospective study of salvage radiotherapy combined with horrmone therapy for high-risk recurrent prostate cancer after radical prostatectomy
The SAHOP study
A prospective study of salvage radiotherapy combined with horrmone therapy for high-risk recurrent prostate cancer after radical prostatectomy
The SAHOP study
Japan |
Recurrent prostate cancer after radical prostatectomy
Urology |
Malignancy
NO
The evaluation of clinical efficacy of salvage radiotherapy combined with horomone therapy for reuccurent prostate cancer after radical prostatectomy
Safety,Efficacy
Confirmatory
Explanatory
Not applicable
Second biochemical recurrence-free survival
1) Salvage hormone therapy-free survival
2) Metastatic-free survival
3) Cancer-specific survival
4) Overall survival
5) Adverse event
6) Body composition analysis after treatment
7) Health-related quality of life after treatment
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine | Other |
Salvage radiotherapy (monotherapy, 70Gy/35fr to the prostate surgical bed)
or
Salvage radiotherapy (70Gy/35fr to the prostate surgical bed) combined with hormone therapy (LHRH analogue and bicalutamide 80mg 1T per day)
20 | years-old | <= |
85 | years-old | >= |
Male
1) History of radical prostatectomy for prostate cancer of clinical stage, T1-T3N0M0
2) Pathological stage, T0, T2, T3
3) Pathological stage, N0 or Nx
4) Continuous elevation of serum PSA level, which is 0.2 ng/mL or more
5) Serum PSA level, 1.0 ng/mL or less
6) No radiographcally-detected recurrent lesions
7) No history of radiotherapy to the pelvic for other malignant diseases
8) Age, 20 to 85 yo
9) ECOG-PS 0 or 2
10) No history of blood transfusion within 28 days before the registration
11) Sufficient organ functions within 28 days before the registration
12) Agreement for enrolment in the study with the signed form
Inappropriate for the enrolment by the judgement of the physician
100
1st name | Makito |
Middle name | |
Last name | Miyake |
Nara Medical University
Department of Urology
634-8522
840 Shijo-cho, Kashihara-shi, Nara, Japan
14072667441
makitomiyake@naramed-u.ac.jp
1st name | Makito |
Middle name | |
Last name | Miyake |
Nara Medical University
Department of Urology
634-8522
840 Shijo-cho, Kashihara-shi, Nara, Japan
0744-22-3051
http://www.naramed-u.ac.jp/~urol/
urology@naramed-u.ac.jp
Department of Urology, Nara Medical University
Department of Urology, Nara Medical University
Self funding
Urology, Nara Prefecture General Medical Center
Urology, Nara City Hospital
Urology, Takai Hospital
Urology, Yamato Takada Municipal Hospital
Urology, Hoshigaoka Medical Center
Urology, Tane General Hospital
Urology, Matsuzaka Chuo General Hospital
Institute of Clinical and Translational Science, Nara Medical University
840 Shijo-cho, Kashihara
0744-22-3051
f-okumura@naramed-u.ac.jp
NO
奈良県立医科大学付属病院
2018 | Year | 04 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2018 | Year | 01 | Month | 10 | Day |
2018 | Year | 03 | Month | 06 | Day |
2018 | Year | 04 | Month | 01 | Day |
2028 | Year | 03 | Month | 31 | Day |
2018 | Year | 01 | Month | 17 | Day |
2022 | Year | 07 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035240
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |